Genetic association between metabolic syndrome and apolipoproteins

Metabolic syndrome, a collection of risk factors for cardiovascular risk factors, refers to a cluster of symptoms, the simultaneous occurrence of which in a person is more likely than the occurrence of each perse. The criteria proposed by the International Diabetes Federation for the diagnosis of this syndrome include central obesity, increased triglycerides, decreased HDL-C, hypertension, and increased fasting blood sugar. Signs of metabolic syndrome can be determined through the interconnected physical and chemical changes in the human body, genetic and environmental factors. One of the most effective factors in metabolic syndrome is change in the lipid profiles. Based on the roles of apolipoproteins in lipid metabolism, the possibility of their role in metabolic syndrome has been documented. The aim of this review is to evaluate the genetic roles of apolipoproteins in metabolic syndrome. Overall, the evidence suggests that the apolipoproteins A particularly APOA5 more associated with this syndrome. On the other hand, despite the prominent role of apolipoprotein B in fat metabolism, there is no evidence on any correlation between B-100 apolipoprotein and lipoproteins such as HDL and triglyceride levels of the symptoms of metabolic syndrome